94 related articles for article (PubMed ID: 2816923)
1. Natural killer lymphocyte blast crisis of chronic myelogenous leukemia.
Warzynski MJ; White C; Golightly MG; Steingart R; Otto RN; Podgurski AE; Johnson ML; Glynn P; Smith DE
Am J Hematol; 1989 Dec; 32(4):279-86. PubMed ID: 2816923
[TBL] [Abstract][Full Text] [Related]
2. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
3. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
4. Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes.
Kahl C; Pelz AF; Bartsch R; Jentsch-Ullrich K; Brückner R; Fostitsch HP; Franke A
Ann Hematol; 2001 Jan; 80(1):58-61. PubMed ID: 11233779
[TBL] [Abstract][Full Text] [Related]
5. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS
J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957
[TBL] [Abstract][Full Text] [Related]
6. Expression of NK-associated antigens in extramedullary lymph nodal blast crisis of chronic myeloid leukemia on fine-needle cytology.
Zeppa P; Marino G; Picardi M; Luciano L; Vetrani A; Palombini L
Diagn Cytopathol; 2002 Sep; 27(3):158-60. PubMed ID: 12203863
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorders of natural killer cells.
Oshimi K
Int J Hematol; 1996 Jun; 63(4):279-90. PubMed ID: 8762811
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
9. Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia.
Henzan H; Yoshimoto G; Okeda A; Nagasaki Y; Hirano G; Takase K; Tanimoto T; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Ann Hematol; 2004 Dec; 83(12):784-8. PubMed ID: 15322764
[TBL] [Abstract][Full Text] [Related]
10. Enhanced NK activity during blast crisis in chronic myelogenous leukemia (CML).
Delwail V; Meseri A; Brizard A; Lecron JC; Sadoun A; Costerousse F; Guilhot F; Tanzer J; Goube de Laforest P
Leuk Res; 1992; 16(6-7):721-2. PubMed ID: 1635387
[No Abstract] [Full Text] [Related]
11. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
12. Involvement of natural killer cells in chronic myeloid leukemia.
Knuutila S; Larramendy ML; Ruutu T; Helander T
Cancer Genet Cytogenet; 1995 Jan; 79(1):21-4. PubMed ID: 7850746
[TBL] [Abstract][Full Text] [Related]
13. Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
Silla LM; Pincus SM; Locker JD; Glover J; Elder EM; Donnenberg AD; Nardi NB; Bryant J; Ball ED; Whiteside TL
Br J Haematol; 1996 May; 93(2):375-85. PubMed ID: 8639431
[TBL] [Abstract][Full Text] [Related]
14. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
15. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
[TBL] [Abstract][Full Text] [Related]
16. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
[TBL] [Abstract][Full Text] [Related]
17. T-cell blast crisis in chronic myelogenous leukemia. Immunophenotypic and molecular biologic findings.
Dorfman DM; Longtine JA; Fox EA; Weinberg DS; Pinkus GS
Am J Clin Pathol; 1997 Feb; 107(2):168-76. PubMed ID: 9024065
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells in chronic leukemia. Function and markers.
Sørskaar D; Førre O; Stavem P
Int Arch Allergy Appl Immunol; 1988; 87(2):159-64. PubMed ID: 2973442
[TBL] [Abstract][Full Text] [Related]
19. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
Smith MR; Mohamed AN; Karanes C
Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
[TBL] [Abstract][Full Text] [Related]
20. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
